Last reviewed 2026-04-23 · How we verify

Restrictive platelet transfusion

Restrictive platelet transfusion involves limiting the number of platelets transfused to patients to prevent complications associated with excessive platelet accumulation.

Restrictive platelet transfusion involves limiting the number of platelets transfused to patients to prevent complications associated with excessive platelet accumulation. Used for Thrombocytopenia for patients undergoing chemotherapy.

At a glance

Mechanism of action

This approach aims to balance the benefits of platelet transfusion in preventing bleeding complications with the risks of thrombotic events. By restricting the number of platelets transfused, clinicians can minimize the risk of adverse outcomes while still providing necessary support to patients with bleeding disorders.

Approved indications

• Thrombocytopenia for patients undergoing chemotherapy

Common side effects

• Thrombotic events

Key clinical trials

• Neonatal Platelet Transfusion Threshold Trial (NA)
• Outcomes of Patient Blood Management in Patients Undergoing Major Surgery
• Coagulation in Cirrhosis (PHASE4)
• Outcomes of Patient Blood Management in Severely Anemic Patients
• Study on Patient Blood Management in Haematological Patients (NA)
• Impact of a Prehospital Identification of Trauma Patients in Need for Damage Control Resuscitation. (NA)
• Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates (PHASE3)
• Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.